Female Pattern Hair Loss (FPHL): Signs and Diagnosis
Your parting is getting wider: is this female pattern hair loss?
More scalp shows along your parting in photographs, your ponytail feels thinner and your crown holds less volume. It is tempting to buy an “anti-hair-loss serum” immediately or book injections. But female pattern hair loss (FPHL, often called female androgenetic alopecia) cannot be reliably diagnosed from one photo or by counting hairs in the shower drain. Temporary shedding after illness, nutritional deficiencies, scalp inflammation and other conditions can look similar.
The key point: FPHL usually develops gradually. Hairs in characteristic areas become finer, the parting widens and the frontal hairline often remains. Treatment may slow further thinning and sometimes restore some density, but complete recovery of former volume cannot be promised. A dermatologist should first identify the cause, especially if shedding began suddenly, the scalp hurts or distinct bald patches have appeared. Earlier treatment may preserve more hair, but diagnosis matters more than buying a procedure.
Why does hair become finer? Is it always hormonal?
FPHL involves miniaturisation: some follicles gradually produce shorter, finer hairs instead of thicker ones. The growth phase may shorten, reducing the overall mass of hair. Genetic susceptibility can come from either side of the family. Thinning becomes more common with age, including after menopause, but can begin earlier.
The term “androgenetic” can wrongly suggest that blood tests must reveal abnormally high “male hormones”. Many women with FPHL have ordinary circulating androgen levels, while follicle sensitivity and other factors vary. However, acne, increased facial hair, irregular periods or other signs of androgen excess deserve assessment. A doctor may evaluate polycystic ovary syndrome or another hormonal condition. Do not start anti-androgen medicines yourself because of how your parting looks.
Distinguish a gradual loss of density from active shedding. Hereditary thinning is often slow, though increased shedding can also occur. Conversely, heavy shedding several months after high fever, surgery, substantial weight loss or childbirth may be telogen effluvium, when many hairs enter a resting phase. Both conditions can coexist. Neither the word “diffuse” nor a daily hair count establishes a diagnosis.
Which signs help determine what to investigate?
| What you notice | One possible explanation | What to do |
|---|---|---|
| The parting widens gradually, especially over the crown; scalp skin looks normal. | Female pattern hair loss | Examine and compare hair-shaft diameters and changes using trichoscopy or dermoscopy. |
| Sudden widespread shedding after physical stress, childbirth, illness or weight loss | Telogen effluvium, possibly alongside FPHL | Create a timeline of events and investigate causes rather than jumping straight to injections. |
| Round bald patches or rapidly appearing separate patches | Alopecia areata or another disease | In-person assessment for a distinct diagnosis and treatment. |
| Redness, painful itching, crusting, scaling or shiny patches without visible follicular openings | Inflammatory or scarring hair loss, sometimes infection | See a dermatologist promptly; certain conditions can permanently destroy follicles. |
| Broken hairs or thinning at the edge of tightly styled hair | Hair shaft damage or traction alopecia | Review styling and haircare; assess inflammation and the duration of traction. |
You can read separately about temporary widespread shedding in telogen hair loss. Here the decision is different: whether hair is gradually miniaturising in a female pattern and how to choose long-term support without overlooking another cause.
What happens at an appointment? Do you need every possible test?
Your doctor will ask how long density has changed, whether relatives have similar thinning and about illnesses, childbirth, medicines or major changes in weight and diet. They will examine the scalp, hairline, other areas and individual hairs. Trichoscopy is magnified inspection that can show variation in hair thickness and signs of inflammation. Standardised parting and crown photographs with consistent lighting and styling can make months-long changes clearer than selfies using different filters.
Not everyone needs extensive hormone tests or a biopsy. With typical findings, diagnosis is often clinical. Depending on symptoms and the history, tests may look for anaemia or iron deficiency, thyroid dysfunction or excess androgens. Where a scarring process cannot be excluded, examining a small scalp sample may help. A large panel without a specific clinical question is usually less informative than a precise timeline of thinning.
Seek timely medical assessment if loss worsens rapidly; the scalp is painful, red or develops pustules or thick crusts; smooth shiny patches appear; the eyebrows thin suddenly; or there are other unusual symptoms. If signs of marked androgen excess appear suddenly or progress quickly — for example, rapid voice deepening alongside increasing facial hair — seek medical assessment without delay, ideally with an endocrinologist. Occasionally, causes other than ordinary female pattern thinning need to be excluded urgently. This is not a reason to wait for a cosmetic appointment.
Which choices make sense once FPHL is confirmed?
The first realistic aim is to slow further thinning. Some people gain density, but not everyone or in every area. The approach depends on age, plans for pregnancy, other conditions, willingness to maintain regular treatment and how many viable follicles remain. Dosing and treatment schedules are individual; social-media advice is not a safe substitute.
| Option | Possible benefit | Key limitation or safety concern |
|---|---|---|
| Topical minoxidil applied to the scalp | One of the best-studied basic treatments; can maintain and sometimes increase hair growth. | Needs consistent use and months of patience; irritation and unwanted hair away from the scalp are possible. |
| Low-dose oral minoxidil | Sometimes considered by a doctor when topical treatment is unsuitable. | Often off-label for FPHL; possible swelling, palpitations, lower blood pressure and facial hair growth. |
| Anti-androgens, such as spironolactone | May help slow progression in some women. | Require clinician selection and risk assessment; avoiding pregnancy and checking drug interactions are essential. |
| Platelet-rich plasma (PRP), low-level light devices, microneedling | Some protocols have promising studies. | Methods and evidence quality vary; these are not guaranteed replacements for established treatment. |
| Parting camouflage, fibres, hairpieces, wigs or transplant in selected circumstances | Can improve appearance immediately, or sometimes for longer in suitable cases. | Camouflage does not treat follicles; transplantation requires assessment of donor hair and ongoing thinning. |
Topical minoxidil comes in different strengths and formulations. Use a product and regimen appropriate to its instructions and chosen with your doctor: licensed uses depend on the country and formulation. Initially shedding may increase temporarily; that does not always mean treatment has failed, but a severe or prolonged response needs reassessment. Scalp irritation or extra hair on the forehead or cheeks after accidental contact are practical drawbacks worth anticipating.
Oral minoxidil and spironolactone are not simply “stronger serum”. Before oral minoxidil, the prescriber considers cardiovascular conditions, blood pressure and other medicines. Before spironolactone, they consider contraindications, kidney function, high potassium risk and pregnancy. Finasteride and other androgen-modifying medicines require particular care in women; US approval of finasteride for men does not make it approved for women. Do not start prescription drugs without clinical assessment.
Pregnancy plans, breastfeeding and menstrual changes
Tell the doctor if you are planning pregnancy, pregnant or breastfeeding before discussing medication or injections. The American Academy of Dermatology advises avoiding minoxidil during pregnancy, while trying to conceive and while breastfeeding. Medicines with anti-androgen effects, including spironolactone, are unsuitable during pregnancy because of potential effects on fetal development. If pregnancy is possible, discuss reliable contraception and plans to conceive with the prescriber before starting such treatment. The prescriber should also advise on stopping times and safer alternatives rather than leaving you to decide alone.
After childbirth, telogen shedding is common and may improve gradually. If your parting was widening beforehand, the two processes can overlap. Do not rush into an expensive “hair restoration course”: first determine what remains after temporary shedding settles. Menopause also does not automatically justify hormone therapy for hair; symptoms, medical history and indications must be considered.
When should you judge the results, and how do you live with the wait?
Hair grows slowly; checking the parting every day can create anxiety without reliably measuring progress. Topical minoxidil is usually assessed after roughly 6–12 months of consistent use, and early shedding sometimes increases temporarily. If treatment helps, maintaining the benefit generally means continuing: stopping may gradually undo the gains.
| Stage | Useful things to record | What to avoid |
|---|---|---|
| Before starting | Diagnosis, scalp condition, consistent baseline photographs of parting and crown, pregnancy plans | Comparing yourself with advertising images that have a different baseline. |
| Early weeks | Irritation, tolerance, changes in shedding and questions for the doctor | Doubling a dose on your own because there is no immediate effect. |
| After several months | Adherence, photographic changes and possible adverse reactions | Changing several treatments at once so you cannot tell what caused an effect. |
| Around 6–12 months | Review density, stability and whether adjustments are needed with your doctor. | Declaring treatment useless on the strength of one unflattering photograph. |
Solutions and tablets do not have social downtime like bruising from injections, but thinning remains visible while you wait for possible improvement. For an upcoming event, changing your parting, using suitable scalp camouflage, finding a fuller-looking cut or wearing a hairpiece are all legitimate ways to feel comfortable now. None interferes with a thoughtful medical decision, and none has to be temporary.
PRP and microneedling have different social effects: the scalp may feel tender or red and show small puncture marks, with timing depending on the protocol. Nobody should promise that such a procedure will be invisible. Ask how long marks may show and when you may wash, style or colour your hair and resume exercise. If useful benefit is not convincingly supported for you, cost and risk may outweigh a hoped-for improvement.
Could shampoo, vitamins or salon procedures be enough?
Shampoo can clean hair and help dandruff but cannot reverse follicle miniaturisation by itself. Massage, oils and “hair-loss cocktails” are often marketed beyond the evidence. Consider vitamins, biotin or iron when there is a diagnosed deficiency or another clinical indication, not as high-dose insurance: excess supplementation can cause harm. Adequate protein, balanced food and gentle haircare matter but cannot replace diagnosis.
If you are interested in devices or PRP, ask which studies actually concern female pattern loss, whether the method was used alongside minoxidil or instead of it, how results were measured and how long patients were followed. Advertising can blur “less shedding” with “greater density”; they are not the same outcome. Exosome injections and other experimental offers should not be treated as standard, proven FPHL therapies.
Transplantation may be considered in certain stable cases, but ongoing diffuse thinning can leave the donor area too sparse. Surgery requires a specialist assessment, not a promise to restore the hair you had at 18. You can also choose no treatment at any age if cost, adverse effects or long-term maintenance are unacceptable to you.
Five questions that keep the choice in your hands
- Which findings point to female pattern thinning, and which suggest telogen, patchy or scarring hair loss?
- Do I need blood tests, and what symptoms justify each one?
- What is my goal: slowing progression, stabilising the parting or hoping for partial regrowth?
- What are the risks or limits for this medicine given my conditions and pregnancy plans, and what should I monitor?
- When will we compare photographs, and what if it does not help or I want to stop?
Be wary of anyone diagnosing you from one photograph, selling a costly test panel without explanation or guaranteeing complete regrowth. It helps to distinguish temporary shedding after illness or childbirth. For detailed medication and procedure regimens, see female pattern hair loss treatment. This page owns the earlier decision: identify the shedding pattern, rule out other causes requiring different care, and agree a realistic long-term plan—or consciously decide against treatment.
Additional questions
Can I colour my hair if I have female pattern thinning?
Colouring does not change the inherited mechanism of miniaturisation, but harsh bleaching and frequent heat styling may break hair shafts and make it look thinner. If the scalp is irritated, discuss care with a dermatologist first.
Will a shorter haircut make me grow more hair?
Cutting hair does not increase follicle numbers, but a fuller shape, softer parting and reduced contrast between scalp and hair can change the appearance of density immediately.
Do I need a genetic test if thinning runs in my family?
Genetic tests are not considered a reliable or necessary routine tool for diagnosing FPHL. Family history helps, but decisions rely on the examination, the pattern of changes and selected investigations when indicated.
Sources
- American Academy of Dermatology — Female pattern hair loss
- American Academy of Dermatology — Hair loss diagnosis and treatment
- British Association of Dermatologists — Female pattern hair loss (October 2024)
- Australian Prescriber (2025) — Male and female pattern hair loss
- DermNet — Female pattern hair loss
- Society for Endocrinology — Evaluation of androgen excess in women (2025)